P. L. Mcgeer And NotNeurite
List of bibliographic references
Number of relevant bibliographic references: 31.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000067 | M. Lee [Canada] ; E. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | NEUROTOXINS RELEASED FROM INTERFERON-GAMMA-STIMULATED HUMAN ASTROCYTES |
| 000697 | J. Miklossy [Canada] ; D. D. Doudet [Canada] ; C. Schwab [Canada] ; S. Yu [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Role of ICAM-1 in persisting inflammation in parkinson disease and MPTP monkeys |
| 000876 | Huw R. Morris [Royaume-Uni] ; John C. Steele ; Richard Crook [États-Unis] ; Fabienne Wavrant-De Vrieze [États-Unis] ; Luisa Onstead-Cardinale [États-Unis] ; Katrina Gwinn-Hardy [États-Unis] ; Nick W. Wood [Royaume-Uni] ; Matthew Farrer [États-Unis] ; Andrew J. Lees [Royaume-Uni] ; P. L. Mcgeer [Canada] ; Teepu Siddique [États-Unis] ; John Hardy [Royaume-Uni, États-Unis] ; Jordi Perez-Tur [États-Unis, Espagne] | Genome-wide analysis of the Parkinsonism-dementia complex of Guam |
| 000A81 | K. Yasojima [Canada] ; W. W. Tourtellotte [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy |
| 000C05 | C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Aβ42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies |
| 000C41 | C. Schwab [Canada] ; M. Schulzer [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam |
| 000C80 | C. Schwab [Canada] ; P. L. Mcgeer [Canada] | Tubulin immunopositive structures resembling intracellular neurofibrillary tangles |
| 000C83 | E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
| 000C89 | C. Schwab [Canada] ; J. C. Steele [États-Unis] ; P. L. Mcgeer [Canada] | Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus |
| 000D07 | D. G. Walker [Canada] ; K. Terai [Canada] ; A. Matsuo [Canada] ; T. G. Beach [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases |
| 000D12 | P. L. Mcgeer [Canada] ; E. G. Mcgeer [Canada] | Glial cell reactions in neurodegenerative diseases : Pathophysiology and therapeutic interventions |
| 000D15 | C. Schwab [Canada] ; H. Akiyama [Japon] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of β-amyloid protein |
| 000D16 | D. G. Walker [Canada] ; T. G. Beach [Canada] ; REN XU [États-Unis] ; J. Lile [États-Unis] ; K. D. Beck [États-Unis] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease |
| 000D82 | P. L. Mcgeer [Canada] ; C. Schwab [Canada] ; E. G. Mcgeer [Canada] ; R. L. Haddock ; J. C. Steele | Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam |
| 000D99 | C. Schwab [Canada] ; J. C. Steele [Canada] ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles |
| 000E15 | C. Schwab [Canada] ; J. C. Steele ; P. L. Mcgeer [Canada] | Neurofibrillary tangles of Guam parkinson-dementia are associted with reactive microglia and complement proteins |
| 000E18 | O. Yasuhara [Canada] ; C. Schwab [Canada] ; A. Matsuo [Canada] ; S. U. Kim ; J. C. Steele ; I. Akiguchi ; J. Kimura ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam |
| 000E32 | C. Schwab [Canada] ; J. C. Steele ; H. Akiyama [Japon] ; P. L. Mcgeer [Canada] | Distinct distribution of apolipoprotein E and β-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam |
| 000E51 | C. Schwab [Canada] ; J. C. Steele ; H. Akiyama ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Relationship of amyloid β/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia |
| 000E94 | I. Tooyama [Canada] ; E. G. Mcgeer [Canada] ; T. Kawamata [Canada] ; H. Kimura ; P. L. Mcgeer [Canada] | Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurons of the substantia nigra during normal aging in humans contrasts with loss in Parkinson's disease |
| 000F09 | O. Yasuhara [Canada] ; T. Kawamata ; Y. Aimi ; E. G. Mcgeer ; P. L. Mcgeer | Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases |
| 000F31 | P. L. Mcgeer [Canada] ; E. G. Mcgeer | Neurotransmitters and their receptors in the basal ganglia |
| 000F37 | I. Tooyama [Canada] ; T. Kawamata [Canada] ; D. Walker [Canada] ; T. Yamada [Canada] ; K. Hanai ; H. Kimura ; M. Iwane ; K. Igarashi ; E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease |
| 000F54 | K. Mizukawa [Canada] ; E. G. Mcgeer ; P. L. Mcgeer | Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, alzheimer disease, and neurologically normal controls |
| 000F83 | T. Yamada [Canada] ; P. L. Mcgeer ; E. G. Mcgeer | Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins |
| 001000 | R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada] | Cerebral glucose metabolism in Parkinson's disease with and without dementia |
| 001072 | R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in Parkinson's and Alzheimer's disease |
| 001073 | T. Yamada ; H. Akiyama ; P. L. Mcgeer | Complement-activated oligodendroglia : a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d |
| 001113 | P. L. Mcgeer ; S. Itagaki ; B. E. Boyes ; E. G. Mcgeer | Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains |
| 001114 | P. L. Mcgeer ; S. Itagaki ; H. Akiyama ; E. G. Mcgeer | Rate of cell death in parkinsonism indicates active neuropathological process |
| 001173 | H. Kamo ; S. U. Kim ; P. L. Mcgeer ; D. H. Shin | Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons |
| This area was generated with Dilib version V0.6.29. |  |